Is Amgen Breaking Out?

Hewlett Packard (HPQ)

Dell (DELL)

Facebook (FB)

Apple (AAPL)

Goldman Sachs (GS)

Fred's First Quarter 2012 EPS Increase 17%

Newell Rubbermaid to Reaffirm Fiscal Year 2012 Outlook

Best ETFs For Facebook Exposure

McDonald's Announces Quarterly Cash Dividend

Is KB HOME Closing in to Resistance?

Is Amgen Breaking Out?

Published on Thursday, 02 February 2012 08:56 Written by Danny Miller

New York, February 2nd (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) closed the trading session at $69.84 just above calculated resistance at $69.63 moving to what appears to be a new range, as this move will clearly raise the attention of momentum buyers.

Amgen Inc. (NASDAQ:AMGN) develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The company concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.

Amgen's stock was trading in a well defined range with support at $56.00 and resistance at $69.63, given that this range was broken traders will be closely monitoring the stock

Amgen Inc (AMGN): Today's Featured Drugs Loser - TheStreet.com
From Earlier: Amgen Announces Analysis Of Rilotumumab Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or Gastroesophageal Cancer - Benzinga
From Earlier: Amgen Announces Analysis Of Rilotumumab Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or Gastroesophageal Cancer - Benzinga
From Earlier: Amgen Announces Analysis Of Rilotumumab Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or Gastroesophageal Cancer - Benzinga
Amgen Stock To Go Ex-dividend Monday (AMGN) - TheStreet.com
Amgen Inc (AMGN): Today's Featured Drugs Winner - TheStreet.com
Amgen Reaches New 52-Week High (AMGN) - TheStreet.com
Benzinga's M&A Chatter for Wednesday April 25, 2012 - Benzinga
Amgen Goes to Turkey, Loses Biotech Cred - TheStreet.com
From Earlier: Amgen to Acquire Mustafa Nevzat; Company Valued at $700M - Benzinga

Real Money Pro from TheStreet: Headlined by legendary hedge fund manager Doug Kass, our team of market technicians and professional traders hand you unique perspectives and breakthrough investment opportunities. Access this exciting service -- Real Money Pro -- FREE, right now!